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Cardiolipin (CL) has recently been shown to be both an anchor and an essential activating platform for caspase-8 on
mitochondria. These platforms may be at the mitochondrialcontact sites in which truncated Bid (tBid) has been demonstrated to
be located. A possible role for CL is to anchor caspase-8 at contact sites (between inner and outer membranes), facilitating its
self-activation, Bid-full length (FL) cleavage, tBid generation (and Bax/Bak activation and oligomerization), mitochondrial
destabilization and apoptosis. We have developed an in vitro system that mimics the mitochondrial membrane contact site
platform. This system involves reconstituting caspase-8, Bid-FL and CL complexes in giant unilamellar vesicles (GUVs). We ﬁrst
validated the system by ﬂow cytometry analysis of light-scattering properties and nonyl acridine orange staining of their CL
content. Then, we used ﬂow cytometry analysis to detect the binding of active caspase-8 to CL and the subsequent truncation of
bound Bid-FL. The tBid generated interacts with CL and induces GUV breakage and partial re-vesiculation at a smaller size.
Ourﬁndingssuggestanactiveroleformitochondrialmembranelipids,particularlyCL,inbindingactivecaspase-8andproviding
a docking site for Bid-FL. This phenomenon was previously only poorly documented and substantially underestimated.
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Fas (also called APO-1 or CD95) and its physiological ligand,
FasL, regulate apoptosis of unwanted or dangerous cells, thereby
functioning as a defense against autoimmunity and cancer
development.
1–4 The mechanism by which the ‘death receptor’
FAS triggers the apoptosis of cells depends on the cell type.
1–4
In type I cells, Fas-induced activation of caspase-8 leads to
activationofeffectorcaspasesandsubsequentlycelldeath.In
type II cells, including Barth syndrome-derived hepatocytes
and pancreatic b-cells, cell death requires caspase cascade
ampliﬁcation through caspase-8-mediated activation of the
proapoptotic Bcl-2 family member Bid-FL (BH3 interacting
domain death agonist-full length).
5–7 Caspase-8 cleaves Bid-
FL, which is a member of the Bcl-2 family, and the resulting
truncated Bid (tBid) activates the mitochondria.
8,9 Mitochon-
dria are activated in both type I and type II cells, but this
activation is not strictly necessary for the death of type I cells.
Upon activation, mitochondria release pro-apoptotic mole-
cules, including cytochrome c and Smac/DIABLO.
10 Once in
the cytosol, cytochrome c induces the activation of the
apoptosome leading to the activation of further downstream
caspases and the end result is apoptosis.
The importance of speciﬁc protein–lipid interactions for the
proper functioning of an organelle is clearly exempliﬁed within
the inner membrane (IMM) of mitochondria, in which most
of the unique phospholipid, cardiolipin (CL), is found.
11 CL is
associated with all of the major players in oxidative phosphor-
ylation, including complexes I, III, IV and V, and the major
carrier proteins for adenine nucleotides and phosphates.
12
The absence of CL results in structural abnormalities in the
organization of complexes that have direct functional con-
sequences. CL has been described to be enriched by 10 to
20% in the contact site between the two mitochondrial
membranes.
13 CL is a structurally unusual phospholipid with
one negative charge at physiological pH associated with its
two headgroups and four associated fatty acyl chains.
14 CL is
synthesized by CL synthase, in the matrix-facing leaﬂets of
the IMM.
9 Newly synthesized CL undergoes a remodeling
process during which saturated acyl chains are replaced with
more unsaturated chains, thereby establishing a high degree
of acyl chain symmetry.
CL is associated with several mitochondrial-dependent
apoptotic steps,
15 including the proapoptotic function of Bcl-2
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16andis
subsequently required for Bax activation and the destabiliza-
tion of mitochondrial membrane structure and function.
17 By
anchoring cytochrome c to the IMM, CL both facilitates the
electron transport chain and hinders cytochrome c release
during apoptosis, evidence that complete release of cyto-
chromec requires the disruption of its interactions with CL. CL
peroxidation and degradation facilitates such disruption.
18
Pro-caspase-8 is mostly in the cytosol, but is also
loosely associated with the mitochondrial outer membrane
(OMM).
19,20 We recently reported that Fas receptor activation
induced the translocation of active caspase-8 to the mito-
chondrial surface, a step that was dependent on the presence
of mature CL in the OMM.
21 This translocation of caspase-8
wasnecessaryfortheactivationandampliﬁcationofcaspase-8
processing. Immortalized lymphoblasts from a Barth syndrome
patient containing non-mature CL exhibit a blockage of the signal
transductionthroughmitochondria,showingthatCLisrequiredfor
this process.
Our discovery of an activation platform formed by CL/
Caspase-8/Bid-FL at mitochondrial contact sites
21 opens
various possibilities for research. In particular, more detailed
biophysical analysis of the behavior of active caspase-8 and
of Bid-FL binding is needed to understand the interactions
between the various components of the platform.
Here, we describe the development of an experimental
biomimetic system as a model for studying interactions between
proteins (active caspase-8 and Bid-FL) and the mitochondrial
OMM. It also allows the development of tools for measuring the
effects of binding between the components.
Our approach was to identify a minimal physico-chemical
system that models mitochondrial contact sites and the
interaction of caspase-8/Bid-FL with CL. It involves giant uni-
lamellar vesicles (GUVs) as model membrane system. We ﬁrst
validated ﬂow cytometry for the analysis of GUVs on a routine
basis.Then,weshowhowﬂowcytometrymeasurementscanbe
used to measure binding between GUVs and putative compo-
nents constituting the functional enzymatic platform.
Results
GUV analysis by ﬂow cytometry. Physiological membrane
systems, such as mitochondrial membranes and their contact
sites, are extremely complex. To develop an experimental
model of such systems, we used a cell-free reconstituted
system constituted of GUVs with deﬁned phospholipid
composition. These are the membrane systems that have the
advantages of being freestanding bilayers a few to hundred
micrometers in diameter, suitable for ﬂow cytometry analysis
(Figure 1) and confocal microscopy.
We used this experimental model to study the interactions
between CL and other highly puriﬁed proteins. First, we
validated the use of ﬂow cytometry for the study of GUVs. The
light-scatteringpropertiesofGUVswereusedtofollowvesicle
size changes, and NAO staining was used to measure their
CL content (Figure 1). Beads of deﬁned size were added to
GUV samples to facilitate measuring GUV size (Figure 1a).
Most of the GUVs were larger than the 10mm beads, and in
the range 10 to 100mm in diameter.
The GUVs were homogeneously stained by NAO with
the labeling intensity depending on their size (Figure 1b) and
CL content (Figure 1c). There was a linear relationship
between CL content and NAO ﬂuorescence. We examined
GUVs of various compositions by confocal imaging. This
conﬁrmed the staining of GUVs containing CL by NAO and
weak ﬂuorescence of GUVs devoid of CL (Figure 1 c–e).
The vesicles with 90:10 PC/CL composition appeared
round and mostly devoid of internal structures. They were
also easy to handle. We, therefore, used this GUVs
composition for all subsequent experiments, except where
indicated otherwise.
tBid binds to GUVs containing CL. tBid induces the
destabilization of mitochondrial membranes and changes in
their functional activity
17,22 by binding to the CL at contact
sites. This binding depends essentially on the interaction
between the hairpin-forming domain of tBid and CL both.
24
This also appears to be the case when using CL-containing
phospholipid monolayers.
25
We investigated the binding and effects of tBid on GUVs
containing or not containing CL. tBid did not bind to vesicles
containingonlyphosphatidylcholine(Figure2a,b,eandf),but
showedspeciﬁcbindingtoGUVscontaining CL((Figure2c,d,
g and h). This is consistent with previous ﬁndings concerning
CL-mediated selectivity of tBid interactions with lipid mem-
branes.
16,22,25–28 The weak non-speciﬁc binding did not
modify the light scatter or the ﬂuorescence of PC-only-GUVs
(Figure 2b and f). We then investigated the consequences of
this tBid binding for the light-scattering properties of CL-GUVs
(Figure 2c and g). The addition of 20nM tBid to CL-GUVs
(onlineaddition)wasimmediatelyfollowedbytBidbindingand
a substantial change in light-scattering properties. The
GUVs became smaller and the SSC increased. Indeed, the
CL-GUVs broke down and re-vesiculated at smaller sizes
(39% under 10mm)than the initial and control CL-GUVs vesicles
(29% under 10mm). The tBid ﬂuorescence was clearly asso-
ciated with the low SCC vesicle population (Figure 2h).
Active caspase-8 preferentially binds CL-containing
GUVs. The activation of caspases often involves the
formation of triggering complexes. Many such complexes,
or activation platforms, have been described in the vicinity of
the plasma membrane: the death-inducing signaling-complex
(DISC) for caspase-8 and -10,
29 the apoptososme for
caspase-9,
30 the PIDDosome for caspase-2 and the inﬂam-
masome for caspase-1 and -5.
31 The auto-processing of
caspase-8 into fully active caspase-8 at the DISC involves
two steps. First, upon homodimerization, pro-caspase-8
(p55) is cleaved into two active subunits (p43 and p10).
The second cleavage is in p43 between the DED and the p18
subunits to generate the fully active p18/p10 form. The ﬁrst
cleavage product, p43/p10, associates with CL-containing
membranes and is resistant to alkaline wash, suggesting that
it is inserted into the mitochondrial OMM.
21 Indeed, this was
the ﬁrst proof of caspase-8
32 integration into the mitochon-
drial membrane.
16 The resistance to alkaline washing
suggests that hydrophobic interactions with the unsaturated
acyl chain of CL may contribute to the stability of the complex
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Cell Death and Diseaseformed by CL and p18/p10. However, such bound caspase-8
is sensitive to trypsin proteolysis indicating that it remains
accessible from the cytosol.
21
We investigated the selectivity of the interaction between
caspase-8andGUVsofdifferentlipidcompositions(Figure3).
Vesicles containing and those not containing CL exhi-
bited similar autoﬂuorescence (Figure 3a and c). As added
caspase-8 is not ﬂuorescent, we used an indirect measure-
ment with FITC-VAD-fmk as a reporter of the presence of the
active caspase-8 at the GUV surface (Figure 3 and Table 1).
The binding of active caspase-8 to CL-GUVs was almost
seven times greater than that to PC-only-GUVs (ﬂuorescence
of 853 and 136, respectively, Figure 3b and d). The signal
for PC-only-GUVs presumably relﬂect non-speciﬁc binding.
The ﬁxation of the ﬂuorescent reporter molecule (FITC-VAD-
fmk) to the active site of caspase-8 molecules can be inhibited
by z-VAD-fmk, a widely used pan-caspase inhibitor. z-VAD-
fmk did not affect autoﬂuorescence or non-speciﬁc binding.
We tested the effects of this and other caspase inhibitors on
FITC-VAD-fmk staining of bound active caspase-8 (Table 1).
Both the general caspase inhibitors (z-VAD-fmk and Boc-D-
fmk) and the speciﬁc caspase-8 inhibitor (z-IETD-fmk)
effectively abolished FITC-VAD-fmk staining of caspase-8
linked to GUVs. Bcl-XLDCT,
33 which binds vesicles indepen-
dently of the CL content, did not interfere with this staining
(Table 1).
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Figure 1 Flowcytometryanalysisof GUVs andnonylacridineorangestaining of CL.(a) Light-scattering properties(FSC/SSC)of a GUV preparationcomposedof 90:10
PC/CL. Fluorescent beads (10mm) were included in the sample as size standards. Gates G1 and G2 deﬁne two GUV subpopulations, with G1 for GUVs with FSC lower
thanbeads andG2 for GUVswith FSChigher thanthebeads (theGUVsin this sampleare between 10 to 90mM across).Thenumberof GUVin eachsubpopulationisgiven.
(b) Biparametric histograms of FSC versus NAO ﬂuorescence. The histograms of ﬂuorescence (top left) and FSC (bottom right) are given for the G3 and G4 populations.
(c)RelationshipbetweenGUVcardiolipincontentandNAOﬂuorescence.Alldatareportedcorrespondtoanalysisof2500events.Thevaluesformeanﬂuorescencearegiven
in arbitrary units (a.u.) with S.D. (n¼10). (d–f) Confocal microscopy of GUVs with different CL contents. (d) PC only, (e) PC/CL 90:10 and (f) PC/CL 80:20
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Cell Death and DiseaseFormation of a functional enzymatic complex between
caspase-8, Bid-FL and CL. One hypothesis is that, CL
provides an activation platform upon which caspase-8 can
cluster, oligomerize and be processed into both p43/p10 and
p18/p10. Indeed, the amount of caspase-8 accumulating at
the DISC in type II cells is very small and even not detectable
by western blotting; this led to the suggestion that a
mitochondrial step is necessary for ampliﬁcation (i.e.,
caspase-8 accumulation at the mitochondrial membrane
level and recruitment of Bid-FL).
34 The p43/p10 on the
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Cell Death and Diseaseouter mitochondrial membrane is cross-linked to other p43/
p10 molecules to form high-molecular weight oligomers,
reinforcing this view.
21 This also suggests that caspase-8
processing to its active form (p18/p10) occurs on the
mitochondria and involves a CL-dependent system. Bid-FL
(the substrate), which does not bind to CL, may then be
brought together with caspase-8 (the active enzyme) at this
site in which the interaction produces tBid (the product).
Totestthishypothesis,weﬁrsttargetedactivecaspase-8to
PC-only- and CL-GUVs and then added Alexa-labeled Bid-FL
(Figure 4). The system was highly non-saturable in the
presence of CL and caspase-8. Caspase-8 addition did not
modify either the light scatter or the autoﬂuorescence of the
GUVs (Figure 4a and e). The immediate measurements
(t¼0) correspond to the ﬂuorescence of Bid-FL on CL-GUVs
(Figure 4b and f). In less than two minutes, two populations
were distinguishable in terms of light scattering and of Bid-FL-
Alexa647 (nm) ﬂuorescence (Figure 4c and g). The ﬂuores-
cence of vesicles of high FSC and low SSC (25–30% of the
GUVs) was similar to that of the stained control population,
whereas a new population of low FSC and high SSC (51%)
appearedwithahigherﬂuorescence(Figure4g).Possibly,the
enzymatic system was rapidly active in the presence of the
three components (CL/Caspase-8 and Bid-FL), all together in
the vicinity of the vesicles, such that tBid was generated
and active (similar to the effect of tBid described in Figure 2d
and h). After 45min, only small GUVs with high SCC
were detected in signiﬁcant abundance (30% of all objects
detected). They exhibit weak ﬂuorescence evidence of the
cleavage of the ﬂuorescent Bid-FL-Alexa647 (nm) (Figure 4i)
to generate tBid (non-ﬂuorescent). In parallel, there was
re-vesiculation oftheGUVsatsmaller size(low FSC)andwith
larger side scatter (high SSC) (Figure 4d) and complete
destruction of some (not directly visualized on histograms
because the threshold imposed on the FSC, but nevertheless
calculable). The sequence of events is schematized in
Figure 5, together with a statistical analysis of the generation
of small vesicles (low FSC/high SSC) from the initial
population of GUVs (high FSC/low SSC). It is clear that the
amount of small vesicles generated is smaller than the
number of GUVs initially present (75±7% of the total events).
Figure 5b–d shows the various subpopulations as revealed by
confocal analysis of CL-GUVs stained red with a lipid marker
(and incubated with caspase-8 and Bid-FL-Bopipy 488nm);
the types of vesicles visualized included normal-sized round-
shaped vesicles (over 10mm FSC high/SSC low) (Figure 5b),
small round vesicles (below 10mm FSC low/SSC high)
(Figure5c) andvarious ﬂuorescentdebristhathada tendency
to aggregate (Figure 5d).
Discussion
Given that the amount of active caspase-8 generated at
the DISC during type II cell apoptosis is very low, it seems
likely that the mitochondrial steps are necessary for the
ampliﬁcation of the apoptotic signals required for extrinsic
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Figure 3 Flow cytometry analysis of caspase-8 binding to GUVs containing
CL. FITC-VAD-fmk (500nM), a ﬂuorescent marker of the caspase-8 active site,
was used to stain caspase-8 bound to the vesicles. (a) PC-only-GUV control
(autoﬂuorescenceat488nmexcitation).(b)Bindingofcaspase-8toPC-only-GUVs:
red line, in the absence of z-VAD-fmk (non-ﬂuorescent); black line, following pre-
incubation with 5mM z-VAD-fmk. (c) CL-GUV (composition 90:10 PC/CL) control
(autoﬂuorescence). (d) Binding of caspase-8 to GUVs containing CL (90:10 PC/
CL):blueline,intheabsenceofz-VAD-fmk;blackline,afterpreincubationwith5mM
z-VAD-fmk. Reported values are mean ﬂuorescence and S.D.s for 2500 events
involving GUVs over 10mm in diameter (n¼11)
Table 1 Staining of caspase-8 bound to GUVs with CaspACE in the presence
or absence of caspase inhibitors
CaspACE Caspase-8
inhibitors
Mean ﬂuorescence
in A.U.
— — 7.5±1.9
FITC-VAD-fmk — 138.9±24.5
FITC-VAD-fmk IETD-fmk 35.9±6.9
FITC-VAD-fmk z-VAD-fmk 43.5±7.9
FITC-VAD-fmk Boc-D-fmk 41.5±8.1
Anti-apoptotic
family member
FITC-VAD-fmk Bcl-XLDCt 136.8±25.6
The GUVs were preincubated for 15min with or without caspase inhibitors
and then analyzed by ﬂow cytometry. The ﬂuorescent marker FITC-VAD-fmk
(500nM) was added on-line and measurements were made immediately.
All caspase inhibitors and the anti-apoptotic family member Bcl-XLDCt
(250nm) were pre-incubated with the samples for 30min before addition of
FITC-VAD-fmk.
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Figure 4 Reconstitution of the caspase-8/Bid/CL platform in GUVs. (a–i) Kinetics of Bid-FL activity on CL-GUVs in presence of active caspase-8. CL-containing GUVs
(90:10 PC/CL) pre-treated with 100nM of active caspase-8 were incubated with Alexa647-labeled Bid-FL. Light-scattering properties (FSC/SSC, panels a–d) and Alexa647
ﬂuorescence(panelse–i)oftheGUVsweremeasuredbyﬂowcytometryattime0,2and45minafterincubation.Insertsinpanelaanderepresenttheeffectof theadditionof
active caspase-8 on GUVs. The data are the mean of 12 experiments. (j) CL promotes the binding of Bid-FL to the GUVs in presence of caspase-8 (100nM). PC/CL (100:0)
and PC/CL (90:10) containing GUVs were pretreated with 100nM of active caspase-8 and incubated with increasing concentration of Alexa647-labeled Bid-FL (12.5, 25, 50
and 100nM). Alexa647 ﬂuorescence of the GUVs was measured by ﬂow cytometry
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34 In this work, we tested in a reconsti-
tutedsystem the following hypothesis: active caspase-8binds
to a CL-enriched domain at mitochondrial contact sites in
whichitconstitutesanactivationplatform,
21uponwhichactive
caspase-8 can recruit Bid-FL and process it to generate tBid.
First, we show that the combination of a new biometric
system with a powerful quantitative technique – ﬂow
cytometry – allows systematic and statistically valid studies
of active caspase-8 and Bid-FL interaction with lipid mem-
branes. Using PC-GUVs containing or not containing CL as a
model of mitochondrial contact sites, we were able to
reproduce features of active caspase-8 binding to the
functionalized mitochondrial membranes recently described
using Barth syndrome-derived cell lines.
21 Investigations of
the binding of active caspase-8 is challenging in cells, but is
facilitated in this experimental model. Caspase-8 preferen-
tially binds to CL in GUVs and indeed its non-speciﬁc binding
to PC-GUVs is weak. This is consistent with the view that
active caspase-8 is speciﬁcally targeted to mitochondria upon
activation. This does not resolve the question of the afﬁnity of
the pro-active form of caspase-8 for CL. Nevertheless, such
interaction appears to occur, followed by the recruitment of
further pro-caspase-8 molecules that homodimerize and
undergo the cleavage events necessary for caspase-8
activation. We showed that CL strongly supports the binding
of active caspase-8 to the GUVs. In this study, we have tested
four concentrations of CL (5, 10, 15 and 20%) and found that
5% of CL was sufﬁcient to provide maximal binding of active
caspase-8 to the GUVs (data not shown).
Our investigations are also informative concerning the
possibility of constituting a complete platform composed of
CL/caspase-8 and Bid-FL. After death receptor engagement,
the activationofcaspase-8results inthecleavageofBid-FL to
give a truncated form of tBid.
35 tBid then translocates to
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Figure 5 CL-GUV distribution after formation of caspase-8/Bid-FL platform and image analysis. (a) The two types of GUVs (over 10mm and under 10mm) and the
ﬂuorescent debris in various conditions and after various times (in minutes). In black, the high FSC GUVs and in white, the low FSC GUVs. (b–d) Confocal images after
staining with DiD (0.05% (mol)). Caspase-8 (500nM) and FL-Bid-Alexa647 (100nM) were added sequentially to the GUV preparations. The debris results from the action
of tBid produced by the newly formed enzymatic platform
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leads to cytochrome c release and activation of executioner
caspase-3 and -9. Immunoelectron microcopy suggests that
tBid is targeted in a CL-dependent manner to the contact
sites.
16,25 The minimal requirement of tBid binding to
CL-enriched contact sites was shown to be a-helices 6
36 with
a functional activity toward the respiratory chain linked to
a-helices 6–8.
23 Note that tBid binds to CL and CL derivatives,
such as monolysocardiolipin (MLCL). Consequently, even if
the CL is not mature, tBid can still bind MLCL that is sufﬁcient
for directing tBid translocation to the mitochondria.
We tested the effect of tBid binding to GUVs. We found
unambiguously that tBid binds very efﬁciently and speciﬁcally
toCL-GUVsatnMconcentrations.Moreover,tBidbindingand
its subsequent effects were very fast and induced GUVs
rupture followed by re-vesiculation or even total destruction.
This is consistent with our recent results concerning the
interaction between CL-containing lipid monolayers and the
constitution of lipid microdomains induced by tBid (or by the
hairpin-forming domain of tBid).
23,24 As we can follow tBid
generation on CL-GUVs, we now have a tool for testing the
functional activity of a potential activation platform composed
of CL/caspase-8/Bid-FL.
We found that Bid-FL alone was unable to bind to either
PC-only-GUVs or CL-GUVs (even those containing 20% CL,
result not shown). Although there is some controversy, we
conﬁrmed previous ﬁndings that Bid-FL does not bind to CL.
33
Bid-FL bound to CL-GUVs only if active caspase-8 was
present at the vesicle surface. Active caspase-8 binding to CL
is, in practice, non-saturable, this is also the case for Bid-FL.
We found that the complexes formed very quickly and rapidly
became enzymatically active; the process was too fast to be
followed by imaging of GUVs by confocal microscopy. Within
2min, the CL-GUVs samples exhibited two subpopulations
both stained by Bid-FL Alexa647, one similar to the initial or
control GUVs and one composed of smaller GUVs with high
SSC. After 45min the initial CL-GUV population and its
ﬂuorescence associated with Bid-FL had been lost (because
the truncated form is non-ﬂuorescent). A third population of
components was also generated by the activity of the
platform: ﬂuorescent debris from broken GUVs with high
ﬂuorescence and a tendency to aggregate.
Studies with our model vesicles indicate that active capase-
8 binds to CL, and Bid-FL subsequently binds to the ﬁxed
active caspase-8 at its cleavage site leading to tBid genera-
tion. tBid is in turn the driving force destabilizing the vesicles,
presumably through increased membrane curvature as
described by Epand et al.
26 Indeed, our approach, based on
ﬂow cytometry with the newly developed biomimetic model of
mitochondrial contact sites, strongly supports the hypothesis
of the formation of a platform composed of caspase-8 and
Bid-FL bound to CL. Our major ﬁnding is that Bid-FL requires
the presence of caspase-8 for binding to GUVs, and this
provides further insight into the nature of the so-called
‘mitosome’-triggering complex.
Materials and Methods
Protein preparation. We prepared ﬂuorescently labeled human tBID as
described
37 from BID complementary (cDNA) in pET15b encodinga single cysteine
at position 64 in the tBID fragment, and labeled it with Alexa647 maleimide
(Invitrogen, Cergy-Pontoise, France).
33 We puriﬁed full-length BID by the same
protocolasthatusedfortBID,butfromacDNAwithC15SandC28Smutations,and
labeled it with Bodipy or Alexa647 maleimide.
33 Bcl-XLDC was prepared as
described
33 by Garcia-Saez et al.
33
Preparation of GUVs. All lipids were from Avanti Polar Lipids (Alabaster, AL,
USA). We prepared GUVs by the electroformation method. We spread 5ml of lipid
mixture at 1mg/ml in chloroform on two Pt wire electrodes. We immersed the lipid
ﬁlms in a chamber containing 300mM sucrose solution and connected the Pt wires
to a power generator. Electroformation was at 2.3V and 10Hz for 1h at room
temperature, and the GUVs formed were released from the electrodes by changing
the frequency to 2Hz for 30min.
33
Protein binding and image analysis. Aliquots of 50ml of the
electroformed GUVs were sedimented in 500ml PBS containing the
corresponding proteins. GUV labeling was assessed by confocal microscopy. We
added 25nM of nonyl acridine orange (NAO) to reveal the presence or absence of
CL; after 30min of incubation at room temperature the resulting ﬂuorescence was
measured in the green channel. DiD (DiIC18(5), 0.05% (mol)), a lipophilic
carbocyanine dye, was used to vizualize vesicles, imaged in the red channel,
independently of their CL content. We used an LSM 510 Meta microscope (Zeiss,
Jena, Germany) with a 40 1.2 NA C-Apochromat water objective (Zeiss) in the
multi-track mode. UV/488/543/633 and 545nm ﬁlters were used as main and
secondary dichroics. The green channel consisted of an Ar laser with excitation
wavelength at 488nm and a 505–530-nm band-pass ﬁlter, whereas we conﬁgured
the red channel with a 633-nm excitation laser and a 650-nm long-pass ﬁlter.
Flow cytometry analysis of GUVs. For ﬂow cytometry analysis, pre-
incubation when appropriate was performed with 10ml of electroformed GUVs in
100ml of PBS (subsequently made up to 1ml in PBS for ﬂow cytometry analysis).
The pre-incubated GUVs were sedimented and the pellet was washed to eliminate
non-speciﬁc binding of dyes and proteins. Some current experiments were
performed on-line in the ﬂow cytometer, in which case 10ml of the GUV preparation
wasdilutedto 1mlin PBSandthenpassedthroughtheﬂow cytometer;thereaction
was started by addition of proteins directly to the tube during data recording and the
enzymatic activity was measured either as changes in light scatter or by
ﬂuorescence measurement. Forward low-angle light scatter (FSC) and side scatter
(SSC) were recorded. We measured NAO ﬂuorescence in the green channel. We
checked that non-speciﬁc binding of proteins was limited in parallel experiments
involving sedimentation of GUVs in dye- or protein-free media (data not shown).
We used CaspACE FITC-VAD-fmk (Promega, Charbonnieres, France), a
ﬂuorescent derivative of VAD-fmk, at 500nM to stain the active site of caspase-8
(100nM, non-labeled) bound to GUVs. We performed control experiments with the
non-ﬂuorescent caspase-8 inhibitors Z-VAD- fmk (5mM), Boc-D-fmk (500nM) and,
more speciﬁc for caspase-8, Z-IETD-fmk (500nM). The amount of FL-Bid Alexa647
added is always 100nM.
We used a FACS Calibur4C (Becton-Dickinson, Franklin Lakes, NJ, USA)
equipped with an argon laser at 488nm and a red diode laser at 635nm. A
530±30nm band pass ﬁlter was used for green ﬂuorescence (448nm excitation)
anda661±16nmbandpassfortheredﬂuorescence(excitation635nm).Beadsof
known size (10mm diameter) were added to the samples as size markers when
appropriate.Giventhestrengthofthelight-scatteringpropertiesoftheGUVsusedin
ourstudy,werecordedtheFSCandtheSSC,andaparticlethresholdwassetonthe
FSC to exclude debris and very small particles.
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgements. This work was supported by the Association Franc ¸aise
contre les Myophaties (grant number 11557 and to PXP). We thank Jean-Claude
Martinou (University of Geneva, Switzerland) for providing us with puriﬁed active
caspase-8.
1. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29–55.
2. Krammer PH. CD95’s deadly mission in the immune system. Nature 2000; 407: 789–795.
GUVs as a new tool for analysis of caspase-8/Bid-FL complex
O Jalmar et al
8
Cell Death and Disease3. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK et al. The CD95
receptor: apoptosis revisited. Cell 2007; 129: 447–450.
4. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune
system. Immunity 2009; 30: 180–192.
5. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ. BID: a novel BH3 domain-only
death agonist. Genes Dev 1996; 10: 2859–2869.
6. Yin XM,WangK,GrossA, ZhaoY, ZinkelS,Klocke Betal.Bid-deﬁcientmiceareresistant
to Fas-induced hepatocellular apoptosis. Nature 1999; 400: 886–891.
7. McKenzie MD, Carrington EM, Kaufmann T, Strasser A, Huang DC, Kay TW et al.
Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of
pancreatic beta-cells. Diabetes 2008; 57: 1284–1292.
8. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a bcl-2 interacting protein,mediates
cytochrome c release from mitochondria in response to activation of cell surface receptors.
Cell 1998; 94: 481–490.
9. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial
damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501.
10. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role
of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet.
Cell Death Differ 2002; 9: 1031–1042.
11. Schlame M, Haldar D. Cardiolipin is synthesized on the matrix side of the inner membrane
in rat liver mitochondria. J Biol Chem 1993; 268: 74–79.
12. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin.
Prog Lipid Res 2000; 39: 257–288.
13. Ardail D, Privat JP, Egret-Charlier M, Levrat C, Lerme F, Louisot P. Mitochondrial contact
sites. Lipid composition and dynamics. J Biol Chem 1990; 265: 18797–18802.
14. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial
membranes. J Lipid Res 2008; 49: 1607–1620.
15. Gonzalvez F, Gottlieb E. Cardiolipin: setting the beat of apoptosis. Apoptosis 2007; 12:
877–885.
16. Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X. Cardiolipin provides speciﬁcity for
targeting of tBid to mitochondria. Nat Cell Biol 2000; 2: 754–761.
17. Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B et al. tBid
interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and
subsequently activates Bax and Bak. Cell Death Differ 2005; 12: 614–626.
18. Kagan E, Tyurin VA, Jiang JY, Tyurina YY, Ritov VB, Amoscato AA et al. Cytochromme c
acts as a cardiolipoin oxygenase required for release of proapoptotic factors. Nature
Chemical Biology 2005; 1: 223–232.
19. Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andra K, Seper M et al. Identiﬁcation
of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and
tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol 2000; 20: 5665–5679.
20. Stegh AH, Barnhart BC, Volkland J, Algeciras-Schimnich A, Ke N, Reed JC et al.
Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for
the bifunctional apoptosis regulator protein. J Biol Chem 2002; 277: 4351–4360.
21. Gonzalvez F, Schug ZT, Houtkooper RH, Mackenzie ED, Brooks DG, Wanders RJ et al.
Cardiolipin provides an essential activating platform for caspase-8 on mitochondria.
J Cell Biol 2008; 183: 681–696.
22. Gonzalvez F, Bessoule JJ, Rocchiccioli F, Manon S, Petit PX. Role of cardiolipin on
tBid and tBid/Bax synergistic effects on yeast mitochondria. Cell Death Differ 2005; 12: 659–667.
23. Gonzalvez F, Pariselli F, Jalmar O, Dupaigne P, Sureau F, Dellinger M et al. mechanistic
issues oftheinteractionofthehairpin-formingdomainoftBidwithmitochondrialcardiolipin.
PLoS One 2010; 5: v9342.
24. Petit PX, Dupaigne P, Gonzalvez F, Pariselli F, Bernard S. tBid-induced alterations of lipid
monomalyers initially depends on H6/H7 peptides forming hairpin domain-cardiolipin
relationship: a biophysical approach. FEBS J 2009; 276: 6338–6354.
25. Lutter M, Perkins GA, Wang X. The pro-apoptotic Bcl-2 family member tBid localizes to
mitochondrial contact sites. BMC Cell Biol 2001; 2: 22.
26. Epand RF, Martinou JC, Fornallaz-Mulhauser M, Hughes DW, Epand RM. The Apoptotic
Protein tBid Promotes Leakage by Altering Membrane Curvature. J Biol Chem 2002; 277:
32632–32639.
27. Kim TH, Zhao Y, Ding WX, Shin JN, He X, Seo YW et al. Bid-cardiolipin interaction at
mitochondrial contact site contributes to mitochondrial cristae reorganization and
cytochrome c release. Mol Biol Cell 2004; 15: 3061–3072.
28. Liu J, Weiss A, Durrant D, Chi NW, Lee RM. The cardiolipin-binding domain of Bid
affects mitochondrial respiration and enhances cytochrome c release. Apoptosis 2004; 9:
533–541.
29. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH et al.
Cytotoxicity-dependent Apo-1 (FAs/CD95)-associated proteins form a death-inducing
signaling complex (DISC) with the receptor. EMBO J 1995; 14: 5579–5588.
30. Zou H, li Y, Liu X, Wang X. An APAF-1.cytochrome c multimeric complex is
a functional apoptososome that activates procaspase-9. J Biol Chem 1999; 274:
11549–11556.
31. Martinon F, Burns K, Tschopp J. The inﬂammasome: a molecular platform triggering
activation of inﬂammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:
417–426.
32. TinelA,TschoppJ.ThePIDDosome,aproteincompleximplicatedinactivationofcaspase-
2 in response to genotoxic stress. Science 2004; 304: 843–846.
33. Garcia-Saez AJ, Ries J, Orzaez M, Perez-Paya E, Schwille P. Membrane promotes tBID
interaction with BCL(XL). Nat Struct Mol Biol 2009; 16: 1178–1185.
34. Scafﬁdi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two CD95
(APO-1/Fas) signaling pathways. Embo J 1998; 17: 1675–1687.
35. GrossA,YinXM,WangK,WeiMC,JockelJ,MillimanCetal.CaspasecleavedBIDtargets
mitochondria and is required for cytochrome c release, while BCL-XL prevents this release
but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999; 274: 1156–1163.
36. Hu X, Han Z, Wyche JH, Hendrickson EA. Helix 6 of tBid is necessary but not sufﬁcient for
mitochondrial binding activity. Apoptosis 2003; 8: 277–289.
37. Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. Posttranslational N-myristoylation of
BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000; 290:
1761–1765.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensedundertheCreativeCommonsAttribution-Noncommercial-Share
Alike3.0UnportedLicense.Toviewacopyofthislicense,visithttp://
creativecommons.org/licenses/by-nc-sa/3.0/
GUVs as a new tool for analysis of caspase-8/Bid-FL complex
O Jalmar et al
9
Cell Death and Disease